000			02244 a2200625 4500
005			20250516005356.0
264		0	_c20110503
008			201105s 0 0 eng d
022			_a1523-1755
024	7		_a10.1038/ki.2010.382 _2doi
040			_aNLM _beng _cNLM
100	1		_aHasegawa, Takeshi
245	0	0	_aChanges in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. _h[electronic resource]
260			_bKidney international _cFeb 2011
300			_a340-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAmbulatory Care _xlegislation & jurisprudence
650	0	4	_aAnemia _xblood
650	0	4	_aBiomarkers _xblood
650	0	4	_aDrug Costs
650	0	4	_aDrug Utilization _xlegislation & jurisprudence
650	0	4	_aErythropoietin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHealth Expenditures _xlegislation & jurisprudence
650	0	4	_aHealth Policy _xeconomics
650	0	4	_aHematinics _xadministration & dosage
650	0	4	_aHemoglobins _xmetabolism
650	0	4	_aHumans
650	0	4	_aInsurance, Health, Reimbursement _xlegislation & jurisprudence
650	0	4	_aIron _xadministration & dosage
650	0	4	_aJapan
650	0	4	_aKidney Failure, Chronic _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNational Health Programs _xeconomics
650	0	4	_aOutcome and Process Assessment, Health Care _xeconomics
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aPractice Patterns, Physicians' _xeconomics
650	0	4	_aProspective Studies
650	0	4	_aRecombinant Proteins
650	0	4	_aRenal Dialysis _xeconomics
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aBragg-Gresham, Jennifer L
700	1		_aPisoni, Ronald L
700	1		_aRobinson, Bruce M
700	1		_aFukuhara, Shunichi
700	1		_aAkiba, Takashi
700	1		_aSaito, Akira
700	1		_aKurokawa, Kiyoshi
700	1		_aAkizawa, Tadao
773	0		_tKidney international _gvol. 79 _gno. 3 _gp. 340-6
856	4	0	_uhttps://doi.org/10.1038/ki.2010.382 _zAvailable from publisher's website
999			_c20265446 _d20265446